<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:ifp="http://www.ifactory.com/press" xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9">
  <ifp:contentType>ARTICLE</ifp:contentType>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p745.xml</sm:loc>
    <ifp:title>Should Resource Constraints Guide Global Guidelines?</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p753.xml</sm:loc>
    <ifp:title>Barriers to Clinical Trial Participation as Perceived by Oncologists and Patients</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p766.xml</sm:loc>
    <ifp:title>Point: Combination Versus Single-Agent Chemotherapy: The Argument for Sequential Single Agents</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p771.xml</sm:loc>
    <ifp:title>Counterpoint: The Argument for Combination Chemotherapy in the Treatment of Metastatic Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p774.xml</sm:loc>
    <ifp:title>Breast Risk Reduction</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p800.xml</sm:loc>
    <ifp:title>Breast Cancer Risk Reduction and Counseling: Lifestyle, Chemoprevention, and Surgery</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p809.xml</sm:loc>
    <ifp:title>Diet and Breast Cancer Risk Reduction</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p817.xml</sm:loc>
    <ifp:title>The STAR Trial: Evidence for Raloxifene as a Breast Cancer Risk Reduction Agent for Postmenopausal Women</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p824.xml</sm:loc>
    <ifp:title>Adult Cancer Pain</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/8/article-p851.xml</sm:loc>
    <ifp:title>Interventional Therapies for Cancer Pain Management: Important Adjuvants to Systemic Analgesics</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
</urlset>
